[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8401538L - IMPROVED ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING COFFEE AND PROCEDURES FOR USING THESE - Google Patents

IMPROVED ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING COFFEE AND PROCEDURES FOR USING THESE

Info

Publication number
SE8401538L
SE8401538L SE8401538A SE8401538A SE8401538L SE 8401538 L SE8401538 L SE 8401538L SE 8401538 A SE8401538 A SE 8401538A SE 8401538 A SE8401538 A SE 8401538A SE 8401538 L SE8401538 L SE 8401538L
Authority
SE
Sweden
Prior art keywords
analgetic
procedures
improved
analgesic
compositions including
Prior art date
Application number
SE8401538A
Other languages
Swedish (sv)
Other versions
SE8401538D0 (en
SE466481B (en
Inventor
A Sunshine
E M Laska
C E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of SE8401538D0 publication Critical patent/SE8401538D0/en
Publication of SE8401538L publication Critical patent/SE8401538L/en
Publication of SE466481B publication Critical patent/SE466481B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Novel analgesic and anti-inflammatory compositions of matter for use in eliciting an analgesic or anti-inflammatory response, said compositions comprising caffeine together with a selected non-narcotic analgesic/nonsteroidal anti-inflammatory drug or a selected narcotic analgesic, or both. When used in combination with the selected drugs, caffeine enhances the analgesic or anti-inflammatory response and also hastens its onset.
SE8401538A 1982-07-22 1984-03-20 ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING COFFEE SE466481B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
PCT/US1983/001121 WO1984000488A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Publications (3)

Publication Number Publication Date
SE8401538D0 SE8401538D0 (en) 1984-03-20
SE8401538L true SE8401538L (en) 1984-03-20
SE466481B SE466481B (en) 1992-02-24

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401538A SE466481B (en) 1982-07-22 1984-03-20 ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING COFFEE

Country Status (15)

Country Link
JP (3) JPS59501460A (en)
AT (2) AT389226B (en)
AU (1) AU558485B2 (en)
BE (1) BE897356A (en)
CA (1) CA1217429A (en)
CH (1) CH659391A5 (en)
DE (1) DE3390116C2 (en)
FR (1) FR2530469A1 (en)
GB (1) GB2134786B (en)
IE (1) IE55367B1 (en)
IT (1) IT1206502B (en)
NL (1) NL191432C (en)
SE (1) SE466481B (en)
WO (1) WO1984000488A1 (en)
ZA (2) ZA835324B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (en) * 1985-02-08 1988-02-15 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION.
CH669523A5 (en) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
BR0205721A (en) 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Controlled Release Oxymorphone Formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (en) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd Fatigue recovery agent
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP7523879B2 (en) * 2016-10-31 2024-07-29 エスエス製薬株式会社 Pharmaceutical Compositions
JP2021054728A (en) * 2019-09-27 2021-04-08 興和株式会社 Pharmaceutical
JP6811453B1 (en) * 2020-06-24 2021-01-13 医療法人すぎやま内科 Composition for transdermal absorption

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
NL191432B (en) 1995-03-01
GB2134786A (en) 1984-08-22
DE3390116C2 (en) 1994-06-16
BE897356A (en) 1983-11-14
IE831715L (en) 1984-01-22
CH659391A5 (en) 1987-01-30
ATA245988A (en) 1989-08-15
AU558485B2 (en) 1987-01-29
AU1881683A (en) 1984-02-23
JPH07165583A (en) 1995-06-27
SE8401538D0 (en) 1984-03-20
ZA835326B (en) 1984-09-26
NL191432C (en) 1995-07-04
CA1217429A (en) 1987-02-03
IE55367B1 (en) 1990-08-29
NL8320240A (en) 1984-06-01
GB2134786B (en) 1986-05-08
SE466481B (en) 1992-02-24
AT389998B (en) 1990-02-26
ATA903983A (en) 1989-04-15
JPS59501460A (en) 1984-08-16
GB8406704D0 (en) 1984-04-18
JPS59501459A (en) 1984-08-16
IT1206502B (en) 1989-04-27
AT389226B (en) 1989-11-10
ZA835324B (en) 1984-09-26
FR2530469A1 (en) 1984-01-27
IT8322173A0 (en) 1983-07-21
WO1984000488A1 (en) 1984-02-16
DE3390116T1 (en) 1985-01-10

Similar Documents

Publication Publication Date Title
SE8503762D0 (en) ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING XANTINES AND PROCEDURE FOR USING THESE
IT1206501B (en) ANALGESIC, AND ANTI-INFLAMMATORY COMPOSITIONS IMPROVED, CONTAINING CAFFEINE.
SE8401538D0 (en) IMPROVED ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING COFFEE AND PROCEDURES FOR USING THESE
ES548168A0 (en) PROCEDURE FOR PREPARING COMPOSITIONS FOR COSMETIC OR PHARMACEUTICAL USE BASED ON LIPIDIC SPHERULES CONTAINING A POLYAMIDE POLYMER.
ATE2616T1 (en) 1-ARYL-2-ACYLAMIDO-3-FLUORO-1-PROPANOLS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK372786D0 (en) PHARMACEUTICAL PREPARATIONS OF PHENINDAMINE
DE3586545D1 (en) INCREASED PAINLESSNESS PHARMACEUTICAL COMPOSITIONS.
DE69018647D1 (en) DRUG.
SE8401537D0 (en) IMPROVED ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING THE IBUP PROFESSION AND WAY TO USE THESE
IT1212778B (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND / OR ANALGESIC ADAPTERITY, NON ULCEROGENE.
MX9102500A (en) BIPHENYLIUM COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
DE3784595D1 (en) MEDICINE AGAINST FIXED TUMORS.
NO882562D0 (en) NEW 2-GUANIDINO-TIAZOL COMPOUNDS PROCEDURE FOR THE PREPARATION AND USE thereof.
IT8219216A0 (en) AND RELATED PHARMACEUTICAL COMPOSITIONS COMPOSED WITH ANTI-INFLAMMATIC, ANALGESIC AND MUCOREGULATORY ACTIVITIES, PROCEDURE FOR ITS PREPARATION
DE3871159D1 (en) PHARMACEUTICAL AND VETERINARY COMPOSITIONS.
FR2677477B1 (en) NEW OXAZOLE DERIVATIVES, THEIR PREPARATION, THEIR USE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IT8721998A0 (en) PROCEDURE AND DEVICE FOR THE STABILIZED GUIDANCE OF A SURFACE FOR MOVING MATERIALS SLIDING.
NL170855B (en) MEDICINAL PROPERTIES AGAINST ATHEROMA AND THE PYRIMIDINE DERIVATIVES THEREIN.
FI793039A (en) OCTAHYDRO-1H-BENZO (4,5) -FURO (3,2-E) -ISOKINOLINER WITH ANALGETIC AND DRUG TAGONISTIC EGENSKAPER
IT9048026A0 (en) PHARMACEUTICAL AND/OR COSMETIC PREPARATION.
SE8504612D0 (en) ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING DIPHENHYDRAMIN AND PROCEDURES FOR USING THESE
ATE45160T1 (en) SESQUITERPEN LACTONES, EXTRACTS CONTAINING THESE, THEIR PREPARATION AND PHARMACEUTICAL USE.
ATE10191T1 (en) 1-SULFO-2-AZETIDINONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
BR9100824A (en) FLAVORED CIGARETTE FOR THERAPEUTIC AND SOCIAL USE
ZA835760B (en) 2-substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-beta-carbolines,their preparation and their use as drugs

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401538-7

Format of ref document f/p: F

NUG Patent has lapsed